Status: For immediate public release
ALTAPURE SUCCESSFULLY RESOLVES ITS SUIT AGAINST SURFACIDE, LLC FORCING THE COMPANY TO REMOVE ALL OF ITS FALSE MARKETING CLAIMS FROM ITS WEBSITE AND SALES MATERIALS.
(Mequon, WI) During the discovery proceedings, and after the oral depositions of Jeff Veehuis and Adam Buchakian and half way through the deposition of Gunner Lylso, Surfacide abruptly agreed to remove all of its false and misleading statements regarding its UV light technology. It was patently obvious that executives and managers of Surfacide are not educated in the field of infection control or the supporting sciences. The depositions confirmed that UV light products are extremely limited to those surfaces in line of sight and with the effective distance from the light source. Further, despite the use of three emitters, shadowing remains a clear deficiency prohibiting the technology from obtaining a complete kill on all surfaces in a treated space.
In as much publicized study in the Journal of Infection Control and Hospital Epidemiology, September 2018, Vol. 39, a study group at Sloan Kettering Cancer Center concluded, ”Utilization of UV disinfection to supplement routine terminal cleaning of rooms was not effective in reducing hospital acquired VRE and C. difficile among SCT recipients”. These results are similar to other published studies.
None of the UV light products have been shown to be able to meet the performance standards imposed on all chemical products, when claiming the ability to disinfect and/or sterilize, by the United States Environmental Protection Agency (EPA). It is the “wild west” for the UV light industry because there has been no Federal Agency that has asserted supervisory jurisdiction over these products.
THE ALTAPURE HIGH-LEVEL DISINFECTION SYSTEMS (HLDS) ARE NOT EFFECTED BY SHADOWING OR DISTANCE.
WHY CHOOSE AN INFERIOR PRODUCT WHEN LIFE IS AT STAKE?